Aspa Therapeutics recently brought together patient group leaders and medical thought leaders, including Canavan Foundation president Orren Alperstein, to begin a conversation about the needs of the Canavan disease community. Aspa was formed recently to advance the gene therapy for Canavan Disease developed by Dr. Guangping Gao towards clinical trials. <more>